Suppr超能文献

HbA1c 水平与慢性高血糖症状之间是否存在阈值?

Is there an HbA1c Threshold for Symptoms of Chronic Hyperglycemia?

机构信息

Department for Internal Medicine III, Jena University Hospital, Jena, Germany.

Jena University Hospital, Center for Clinical Studies, Jena, Germany.

出版信息

Exp Clin Endocrinol Diabetes. 2022 Jun;130(6):386-392. doi: 10.1055/a-1493-0683. Epub 2021 Jun 7.

Abstract

AIMS OF THE STUDY

The minimum therapeutic goal regarding metabolic control for people with diabetes mellitus is the "absence of symptoms of hyperglycemia." However, it is uncertain whether a level of HbA1c can be defined that guarantees the absence of these symptoms. The aim was to define an HbA1c threshold above which most patients show hyperglycemic symptoms.

METHODS

In a multicenter cross-sectional study, 137 patients with type 1 and 285 with type 2 diabetes were asked about their symptoms during periods of hyperglycemia with a standardized questionnaire. Seventeen symptoms of hyperglycemia were summarized to the total hyperglycemia symptom score (THSS; min. 0; max. 68). The answers could be given according to the frequency and intensity in the last 4 - 6 weeks.

RESULTS

The HbA1c threshold above which most patients showed hyperglycemic symptoms was 10.05% for patients with diabetes type 1 and 8.9%. for patients with type 2. Most confidence was reached on the symptoms of frequent urination" and "tiredness." The mean THSS was 19.4 (±9.0) and showed a positive correlation with age (r=0.167; p<0.001) and HbA1c (r=0.254; p<0.001).

CONCLUSIONS

We identified an HbA1c threshold above which most patients show symptoms of hyperglycemia. In the treatment of people with diabetes mellitus, a safety margin to this threshold should be maintained to preserve well-being and avoid distress. However, since hyperglycemia symptoms are subject to many influencing factors, an adjustment of the therapy-both intensification and de-intensification-should always be carried out in combination with the requested hyperglycemia symptoms and HbA1c value.

摘要

研究目的

糖尿病患者代谢控制的最低治疗目标是“无高血糖症状”。然而,目前尚不确定是否可以定义一个 HbA1c 水平,以保证不存在这些症状。本研究旨在确定一个 HbA1c 阈值,超过该阈值的大多数患者会出现高血糖症状。

方法

在一项多中心横断面研究中,137 例 1 型糖尿病患者和 285 例 2 型糖尿病患者接受了标准化问卷,询问了他们在高血糖期间的症状。将 17 种高血糖症状总结为总高血糖症状评分(THSS;最小值为 0;最大值为 68)。答案可以根据过去 4-6 周的频率和强度来给出。

结果

1 型糖尿病患者中,大多数患者出现高血糖症状的 HbA1c 阈值为 10.05%,2 型糖尿病患者为 8.9%。大多数患者对“尿频”和“疲劳”等症状的置信度最高。平均 THSS 为 19.4(±9.0),与年龄呈正相关(r=0.167;p<0.001)和 HbA1c(r=0.254;p<0.001)。

结论

我们确定了一个 HbA1c 阈值,超过该阈值的大多数患者会出现高血糖症状。在治疗糖尿病患者时,应在该阈值上保持安全裕度,以保持幸福感并避免痛苦。然而,由于高血糖症状受许多因素影响,治疗方案的调整——无论是强化还是减弱——都应始终与所要求的高血糖症状和 HbA1c 值相结合。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验